Immunotherapy

Category

First Patient Treated in Phase 1 Study Involving Cord Blood-derived Natural Killer Cells in Combo with AFM13 (Innate Cell Engager)

Humans may have an innate ability to fight off cancer and one of the world’s most prominent research centers, University of Texas MD Anderson Cancer Center, recently co-developed a novel regenerative therapy to tap into and actually harness this power to hopefully...

Seattle’s Infectious Disease Research Institute Upbeat by Initial Results of COVID-19 Study Investigating Immunotherapy

Seattle’s Infectious Disease Research Institute, a nonprofit organization, reports positive early results from a clinical trial centering on the use of immunotherapy on COVID-19 patients. According to the organization’s CEO, Dr. Corey Casper, the results are...

Top Oncology Investigator Dr. Anthony Tolcher (Next Oncology) Selected by Heat Biologics to Lead Novel Phase I Oncology Study

Anthony Tolcher, MD, FRCPC, a medical oncologist and co-founder of research organization NEXT Oncology has been appointed the lead investigator for a Phase I clinical trial investigating Heat Biologics’ investigational therapy called PTX-35, a novel potential...

Stakes Get Bigger as Patient Health and Success of Humanigen Platform Depend on Evidence from COVID-19 Clinical Trials

San Francisco Bay Area biotech venture Humanigen, Inc. (HGEN), formerly known as KaloBios Pharmaceuticals, is a clinical stage company focused on preventing and treating cytokine storm with lenzilumab, their proprietary Humaneered® anti-human granulocyte...

Pin It on Pinterest